Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Addeo

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
The Oncologist|January 7, 2010
Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenibBruno Vincenzi, Daniele Santini, Antonio Russo, et al.
Cancers|April 12, 2022
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old ProblemMichela Falco, Chiara Tammaro, Takashi Takeuchi, et al.
Molecular and Cellular Biology|July 30, 2004
Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoterLuigi Cicatiello, Raffaele Addeo, Annarita Sasso, et al.
Cancer Chemotherapy and Pharmacology|August 15, 2012
Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastasesRaffaele Addeo, Pasquale Sperlongano, Liliana Montella, et al.
Molecular and Clinical Oncology|August 30, 2018
Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safetyFerdinando Riccardi, Giuseppe Colantuoni, Anna Diana, et al.
World Journal of Clinical Oncology|December 25, 2024
Paclitaxel for second-line treatment of squamous cell carcinoma of the head and neck: A multicenter retrospective Italian studyMorena Fasano, Mario Pirozzi, Pasquale Vitale, et al.
Oncology Letters|September 14, 2019
Clinical and pathological factors predictive of response to neoadjuvant chemotherapy in breast cancer: A single center experienceSalvatore Del Prete, Michele Caraglia, Amalia Luce, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 19, 2007
Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution reportRaffaele Addeo, Vincenzo Nocera, Vincenzo Faiola, et al.
American Journal of Otolaryngology|February 2, 2021
Sarcomatoid larynx carcinoma differential clinical evolution, on field statistical considerationsFilippo Ricciardiello, Marco Bocchetti, Raul Pellini, et al.
Molecular Therapy. Nucleic Acids|March 18, 2015
MicroRNA-423-5p Promotes Autophagy in Cancer Cells and Is Increased in Serum From Hepatocarcinoma Patients Treated With SorafenibPaola Stiuso, Nicoletta Potenza, Angela Lombardi, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
The Oncologist|January 7, 2010
Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenibBruno Vincenzi, Daniele Santini, Antonio Russo, et al.
Cancers|April 12, 2022
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old ProblemMichela Falco, Chiara Tammaro, Takashi Takeuchi, et al.
Molecular and Cellular Biology|July 30, 2004
Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoterLuigi Cicatiello, Raffaele Addeo, Annarita Sasso, et al.
Cancer Chemotherapy and Pharmacology|August 15, 2012
Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastasesRaffaele Addeo, Pasquale Sperlongano, Liliana Montella, et al.
Molecular and Clinical Oncology|August 30, 2018
Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safetyFerdinando Riccardi, Giuseppe Colantuoni, Anna Diana, et al.
World Journal of Clinical Oncology|December 25, 2024
Paclitaxel for second-line treatment of squamous cell carcinoma of the head and neck: A multicenter retrospective Italian studyMorena Fasano, Mario Pirozzi, Pasquale Vitale, et al.
Oncology Letters|September 14, 2019
Clinical and pathological factors predictive of response to neoadjuvant chemotherapy in breast cancer: A single center experienceSalvatore Del Prete, Michele Caraglia, Amalia Luce, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 19, 2007
Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution reportRaffaele Addeo, Vincenzo Nocera, Vincenzo Faiola, et al.
American Journal of Otolaryngology|February 2, 2021
Sarcomatoid larynx carcinoma differential clinical evolution, on field statistical considerationsFilippo Ricciardiello, Marco Bocchetti, Raul Pellini, et al.
Molecular Therapy. Nucleic Acids|March 18, 2015
MicroRNA-423-5p Promotes Autophagy in Cancer Cells and Is Increased in Serum From Hepatocarcinoma Patients Treated With SorafenibPaola Stiuso, Nicoletta Potenza, Angela Lombardi, et al.
Pageof 11